Press
back to blog

Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers

Press
This is some text inside of a div block.
April 5, 2024

Media Contacts

Related announcements

View All
View All
November 1, 2024

Previewing NeuralPLexer3: Towards fully AI-enabled Structure-Based Drug Discovery

Read more
November 1, 2024

Previewing NeuralPLexer3: Towards fully AI-enabled Structure-Based Drug Discovery

Read more
October 29, 2024

Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery

Read more
October 29, 2024

Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery

Read more
October 29, 2024

Enchant whitepaper: Breaking the data wall between lab and clinic

Read more
October 29, 2024

Enchant whitepaper: Breaking the data wall between lab and clinic

Read more